Latest papers

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method.

Prevalence of serious bleeding events and intracranial hemorrhage in patients receiving activated protein C: a systematic review and meta-analysis.

The use of drotrecogin alfa in severe falciparum malaria.

Troponin-I as a prognosticator of mortality in severe sepsis patients

Use of protein C concentrate in neonatal period.

Hemodynamic effects of recombinant human activated protein C in patients with septic shock

The acute coagulopathy of trauma shock: Clinical relevance

The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Activated protein C improves the severity of severe acute pancreatitis via up-regulating the expressions of endothelial cell protein C receptor and thrombomodulin.

Alveolar dead-space response to activated protein C in acute respiratory distress syndrome.

Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.

Evaluation of the protein C global assay during normal pregnancy and after assisted reproduction.

Markers of proteolysis, fibrinolysis, and coagulation in relation to size and growth rate of abdominal aortic aneurysms.

Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.

Altered reference ranges for protein C and protein S during early pregnancy: Implications for the diagnosis of protein C and protein S deficiency during pregnancy.

The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.

The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.

Haemostatic reference intervals in pregnancy.

Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis.

Natural anticoagulants can be useful predictors of severity in chronic liver disease.